Compounds > mitoxantrone
Page last updated: 2024-10-31

mitoxantrone and Cancer-Associated Pain

mitoxantrone has been researched along with Cancer-Associated Pain in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Cabozantinib treatment did not demonstrate better pain palliation than mitoxantrone-prednisone in heavily pretreated patients with mCRPC and symptomatic bone metastases."2.90Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint. ( Antonarakis, ES; Basch, EM; Bennett, AV; Chi, KN; Dayan, E; de Bono, JS; de Souza, P; Dreicer, R; Dueck, AC; George, S; Holland, J; Hutson, TE; Kalebasty, AR; Mangeshkar, M; Marx, G; O'Sullivan, JM; Scher, HI; Scholz, M; Schwarz, JK; Vaishampayan, U; Vogelzang, N; Weitzman, AL, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basch, EM1
Scholz, M1
de Bono, JS1
Vogelzang, N1
de Souza, P1
Marx, G1
Vaishampayan, U1
George, S1
Schwarz, JK1
Antonarakis, ES1
O'Sullivan, JM1
Kalebasty, AR1
Chi, KN1
Dreicer, R1
Hutson, TE1
Dueck, AC1
Bennett, AV1
Dayan, E1
Mangeshkar, M1
Holland, J1
Weitzman, AL1
Scher, HI1

Trials

1 trial available for mitoxantrone and Cancer-Associated Pain

ArticleYear
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint.
    European urology, 2019, Volume: 75, Issue:6

    Topics: Aged; Analgesics; Anilides; Bone Neoplasms; Cancer Pain; Double-Blind Method; Drug Combinations; Hum

2019